Anti‐drug antibodies and low serum trough infliximab levels correlate with disease activity measures in spondyloarthritis patients on an as‐needed infliximab treatment-Reference-Cited by-同舟云学术

Anti‐drug antibodies and low serum trough infliximab levels correlate with disease activity measures in spondyloarthritis patients on an as‐needed infliximab treatment

Published:2019-06-18 Issue:9 Volume:22 Page:1638-1643
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Patil Abhishek¹^ORCID,Upadhyaya Sundeep¹,Dawar Reetika²,Dadhaniya Nikunjkumar¹,Sood Isha¹,Gupta Sirinder J.¹,Handa Rohini¹^ORCID

Affiliation:

1. Department of Rheumatology Indraprastha Apollo Hospitals Delhi India

2. Department of Microbiology Indraprastha Apollo Hospitals Delhi India

Funder

AHERF

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13636

Reference25 articles.

1. Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study

2. Biologics in spondyloarthritis: TNFα inhibitors and other agents

3. Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis

4. Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab

5. Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐Term Follow‐Up of Anti‐Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering;Arthritis & Rheumatology;2024-07-14

2. Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2024-04-17

3. Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13;BMC Rheumatology;2022-12-07

4. Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives;The Lancet Gastroenterology & Hepatology;2022-02

5. Early monitoring of infliximab serum trough levels predicts long-term therapy failure in patients with axial spondyloarthritis;Scandinavian Journal of Rheumatology;2021-06-29